Price Cut, Generics Hit Pfizer’s Japanese Sales
This article was originally published in PharmAsia News
Executive Summary
Pfizer’s Japanese pharma sales last year were hit not only by the regular biennial reimbursement price cut in April but also by stronger than expected generic competition.